Advertisement

Asia

Evonik completes expansion of methionine production in Singapore

The product carbon footprint of Evonik’s DL-methionine from Singapore has been reduced by 6%.

845834-desktop
SIMEX grand opening. At the ceremony from left to right: Shirley Qi, Regional President of South-East Asia, Australia & New Zealand and Head of Nutrition & Care Asia, Evonik (SEA) Pte Ltd; Claus Rettig, Member of the Extended Executive Board Evonik Industries AG and President Asia Pacific; Dr. Bettina Fanghänel, Ambassador of the Federal Republic of Germany to Singapore; Dr. Harald Schwager, Deputy Chairman of the Executive Board, Evonik Industries AG; Grace Fu, Singapore’s Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations; Johann-Caspar Gammelin, Member of the Executive Board, Evonik Operations GmbH, and President Nutrition & Care; Christine Wong, Assistant Chief Executive Officer of JTC Corporation; Dr. Gaetano Blanda, Senior Vice President and Head of Animal Nutrition business line, Evonik Operations GmbH, and Dr. Christof Gruener, Project Director (Evonik SIMEX), Evonik Methionine SEA Pte Ltd.
August 29, 2024

The expansion of Evonik’s MetAMINO® (DL-methionine) production facilities in Singapore has been completed. The MetAMINO® production on Jurong Island is again running at full capacity, after shutdowns in Q4/2023 and Q2/2024. The production capacity has been increased by 40,000 metric tons, bringing the total to 340,000 metric tons per year. The expansion was accomplished ahead of schedule.

Through process intensification, Evonik has optimized its methionine production plants, generating a surplus of steam that is used to produce on-site electricity. Linde, one of Evonik's partners on Jurong Island, has designed, constructed, and is operating a nine-megawatt alkaline electrolyzer plant, which is the largest of its kind ever installed in Singapore. The unit enables Evonik's efforts to use green hydrogen required for the MetAMINO® production and reflects the company's commitment to sustainability and reducing its environmental impact.

“Our collaboration with Linde on the implementation of green hydrogen in our Singapore facilities is a testament to our commitment to sustainability. We work closely with our partners to build a more sustainable future," said Harald Schwager, deputy chairman of the Executive Board.

Evonik's DL-methionine plants in Singapore have reduced the product carbon footprint of MetAMINO® at this site (Scope 1+2+3) by 6% compared to before the expansion.

The expansion of the MetAMINO® production facilities was inaugurated during a festive ceremony attended by Grace Fu, Singapore’s Minister for Sustainability and the Environment and Minister-in-Charge of Trade Relations. “Evonik's latest expansion will help address two urgent problems – climate change and food production – in a sustainable way. By increasing its product yield with fewer emissions, Evonik's facility will help to feed a growing population while streamlining our carbon footprint. Congratulations to Evonik for paving the way to a more sustainable future,” said Minister Fu.

In 2023, Evonik set its own science-based targets that have been approved by the Science Based Targets Initiative (SBTi) as consistent with a well-below 2°C (WB2C) pathway. “We are committed to reducing emissions in line with the latest climate science, and consequently, we have a long-term ambition to expand our targets to align with a 1.5°C warming pathway, and reach net-zero emissions by 2050”, said Gaetano Blanda, head of the Animal Nutrition business line.